VOPROSY MEDITSINSKOI KHIMII (ISSN 0042-8809)

Effects of cytochrome P-450 inhibitors on macrophage-induced oxidative modification of low density Lipoproteins

   
Dushkin M.I., Zenkov N.K., Pivovarova E.N., Lyubimov G.Yu., Menshikova Ye.B.
Section: Experimental Study
PubMed Id: 8783470
Year: 1996  Volume: 42  Issue: 1  Pages: 23-30
Unlike other cytochrome P450-dependent oxygenase inhibitors, ketoconazole has been shown to suppress the murine macrophage-mediated oxidative modification of human low-density lipoproteins (LDL) in a dose-dependent manner. The benzo[alpha]pyrene-induced microsomal monooxygenase activity was accomplished by a 1,5-fold increase in LDL oxidation by macrophages, ketokonazole (20 mu), methoxalene (20 mu), and alpha-naphthaflavone (50 mu). Ketoconazole was also effective in inhibiting macrophageal NADPH oxidase and LDL autooxidation induced by Fe2+ rather than Cu+, which is likely to be associated with its ability to act as a chelator of free and heme-bound iron ions.
Download PDF:  
Citation:

Dushkin, M. I., Zenkov, N. K., Pivovarova, E. N., Lyubimov, G. Yu., Menshikova, Ye. B. (1996). Effects of cytochrome P-450 inhibitors on macrophage-induced oxidative modification of low density Lipoproteins. Voprosy Meditsinskoi Khimii, 42(1), 23-30.
References